Literature DB >> 20063433

Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies.

Akira Kurita1, Maiko Murakami, Satoshi Takagi, Masato Matsushima, Masahiko Suzuki.   

Abstract

Visual hallucinations (VHs) are common in dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD), while auditory hallucinations are rare. To neurophysiologically investigate the pathophysiology of VHs in these disorders, we studied event-related potentials (ERPs) of DLB, PDD, and Alzheimer's disease (AD) patients. We compared visual and auditory ERP latencies among PDD patients with and without VHs (PDD-H: 11, PDD-N: 6), DLB patients (24), and AD patients (21). To elicit visual and auditory ERPs, a facial discrimination paradigm and a conventional auditory odd-ball paradigm, respectively, were used. The mean visual P3 latencies in the PDD-H and DLB groups were significantly longer than that in the AD group, while the mean auditory P3 latencies in all four patient groups were comparable. The mean visual P2 latencies in the PDD-N, PDD-H, and DLB groups were significantly longer than that in the control group. Our findings suggest that visual cognitive functions are selectively impaired in hallucinatory patients with DLB and PDD. VHs may be associated in part with predominant visual cognitive impairments attributable to PDD and DLB pathologies. Our findings also suggest that the impairments occur at the early stage of facial information processing. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20063433     DOI: 10.1002/mds.22919

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

Review 1.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

2.  Progress Regarding Parkinson's Disease Psychosis: It's No Illusion.

Authors:  Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2016-08-11

Review 3.  Electroencephalogram in dementia with Lewy bodies: a systematic review.

Authors:  Simela Chatzikonstantinou; Jack McKenna; Eleni Karantali; Fivos Petridis; Dimitrios Kazis; Ioannis Mavroudis
Journal:  Aging Clin Exp Res       Date:  2020-05-07       Impact factor: 3.636

Review 4.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

Review 5.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

Review 6.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 7.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

Review 8.  Visual hallucinations in the differential diagnosis of parkinsonism.

Authors:  Kelly Bertram; David R Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-06       Impact factor: 10.154

9.  Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.

Authors:  Ramtin Mehraram; Luis R Peraza; Nicholas R E Murphy; Ruth A Cromarty; Sara Graziadio; John T O'Brien; Alison Killen; Sean J Colloby; Michael Firbank; Li Su; Daniel Collerton; John Paul Taylor; Marcus Kaiser
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

Review 10.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.